Cost-Utility of Interferon Beta-1b in the Treatment of Patientswith a Clinically Isolated Syndrome Suggestive of Multiple Sclerosis
Abt Bio-Pharma Solutions, Inc., Lexington, Massachusetts, USA
Presentation
June 1, 2008
Focus Areas
Capabilities